Search company, investor...

Predict your next investment

Advisory
westfieldcapital.com

Investments

19

Portfolio Exits

11

About Westfield Capital Management

Westfield Capital Management Company, LLC, a SEC-registered investment advisor dedicated to providing quality investment management services to institutions and wealthy individuals, was founded in 1989. Westfield supervises domestic growth equities, with products focusing on each segment of the capitalization spectrum. Investment professionals employ an in-depth, fundamental research process to uncover growth opportunities not yet fully appreciated by the market. Westfield currently manages over $13 billion in client assets.

Headquarters Location

One Financial Center 24th Floor

Boston, Massachusetts, 02111,

United States

Want to inform investors similar to Westfield Capital Management about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing Westfield Capital Management

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Westfield Capital Management in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest Westfield Capital Management News

Harbor Capital Advisors Launches Latest ETF: Health Care Strategy

Nov 17, 2022

November 17, 2022 09:30 AM Eastern Standard Time CHICAGO--( BUSINESS WIRE )--Harbor Capital Advisors, Inc. (“Harbor”), a premier multi-manager investment firm offering access to innovative and specialized expertise across a range of investment strategies and vehicles, launched its latest exchange-traded fund (ETF), the Harbor Health Care ETF (MEDI). This is the 11th ETF for the firm’s growing lineup of ETFs that span several investment themes and asset classes. Along with ETFs, Harbor Capital offers a curated experience of mutual funds and collective investment trusts (CITs). Westfield is a long-term Harbor partner, having managed the Harbor Small Cap Growth Fund since 2000, a sleeve of the Harbor Disruptive Innovation Fund and Harbor Disruptive Innovation ETF since 2021, and the Harbor Dividend Growth Leaders ETF since 2022. MEDI is an active, fully transparent ETF that will seek long-term growth of capital by investing primarily in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry. The health care team at Westfield has deep domain expertise and specialization across the health care sector. Exposures will be broadly diversified across health care industry groups including biotechnology, life sciences, healthcare providers, healthcare equipment, pharmaceuticals, and other subindustries. “We think the health care sector is ripe for exceptional managers to add attractive alpha as the sector expects to benefit from several structural tailwinds such as globally aging populations and advanced science and technology driving drug innovation and treatment. Westfield has proven to be exceptional stock pickers over the past 20 years, particularly in the Healthcare sector and we’re excited to bring that capability directly to the market with this latest thematic offering from Harbor Capital,” said Kristof Gleich, President and CIO, Harbor Capital. MEDI will be led by two of Westfield’s seasoned health care investors. Will Muggia, President, CEO and CIO, has covered the health care sector for over 30 years and Matt Renna, Partner, has over 18 years of health care investing experience. “We are excited to build upon the long-standing partnership with Harbor Capital, by offering investors a pure play vehicle into health care growth equities across the entire market cap spectrum. MEDI seeks to leverage Westfield Capital’s tenured team and process to identify the best secular growth stories within each subsector of health care. Market and sector volatility over the last year has presented compelling investment opportunities in some of the highest quality businesses in U.S. health care, and we are seeing exceptional value in many companies, whose products, technologies, and services offer solutions to all stakeholders within the health care ecosystem. We believe that the convergence of innovation and value-based care within the sector will drive above market shareholder returns over the next decade,” said Matt Renna, Partner, Westfield Capital. About Harbor Capital Harbor Capital is dedicated to helping clients achieve investment objectives with an active, cost-aware investing approach. For more than 30 years, our investment team has served as a guide for clients, developing portfolio strategies based on rigorous research and market analysis; sourcing select specialists and deep insights in each asset class; and evaluating performance to ensure that decisions remain in the best interests of our clients. Headquartered in Chicago, Harbor Capital Advisors had total assets under management of approximately $38 billion as of September 30, 2022. For more information, visit harborcapital.com. About Westfield Westfield Capital Management Company, L.P. is dedicated to providing strong and consistent investment performance based on a disciplined, team-based approach, with exceptional client service. Westfield believes their greatest strength comes from the collective wisdom of a fully engaged and inspired team working together with clear objectives. Additionally, Westfield embraces their employee ownership structure, which aligns the advancement of the organization with their clients, and serves to attract and retain exceptional talent. CALL 1-800-422-1050 TO OBTAIN A PRE-EFFECTIVE PROSPECTUS. BEFORE INVESTING YOU SHOULD CAREFULLY CONSIDER A FUND’S INVESTMENT OBJECTIVES, RISKS, CHARGES, AND EXPENSES. THIS AND OTHER INFORMATION IS IN THE PROSPECTUS. PLEASE READ THE PROSPECTUS CAREFULLY BEFORE YOU INVEST. There is no guarantee that the investment objective of the Fund will be achieved. Stock markets are volatile and equity values can decline significantly in response to adverse issuer, political, regulatory, market and economic conditions. Since the Fund may hold foreign securities, it may be subject to greater risks than funds invested only in the U.S. These risks are more severe for securities of issuers in emerging market regions. Foreign currencies can decline in value and can adversely affect the dollar value of the fund. Since the Fund typically invests in a limited number of companies, an adverse event affecting a particular company may hurt the Fund's performance more than if it had invested in a larger number of companies. Authorized Participant Concentration/Trading Risk: Only authorized participants (“APs”) may engage in creation or redemption transactions directly with the Fund. The Fund is classified as non-diversified. A non-diversified Fund may invest a greater percentage of its assets in securities of a single issuer, and/or invest in a relatively small number of issuers. It is more susceptible to risks associated with a single economic, political or regulatory occurrence than a more diversified portfolio. There can be no assurance that the Fund will grow to or maintain an economically viable size, in which case the Board of Trustees may determine to liquidate the Fund. Small and Mid-Cap Risk: The Fund’s performance may be more volatile because it may invest in issuers that are smaller companies. Unlike mutual funds, ETFs may trade at a premium or discount to their net asset value. The ETF is new and has limited operating history to judge. Shares are bought and sold at market price not net asset value (NAV). Market price returns are based upon the closing composite market price and do not represent the returns you would receive if you traded shares at other times. Alpha is a measure of risk (beta)-adjusted return. Foreside Fund Services, LLC. is the Distributor of the Harbor Health Care ETF. Harbor Funds Distributors, Inc. is the Distributor of the Harbor Small Cap Growth Fund and Harbor Disruptive Innovation Fund. 2578627

Westfield Capital Management Investments

19 Investments

Westfield Capital Management has made 19 investments. Their latest investment was in SevOne as part of their Series C on September 9, 2015.

CBI Logo

Westfield Capital Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/23/2015

Series C

SevOne

$50M

Yes

2

5/10/2011

Series D

BioSet

$6.77M

No

1

2/19/2010

Series B - II

Tepha

$3M

No

9/12/2008

Series C

Subscribe to see more

$99M

Subscribe to see more

0

7/16/2008

Series A

Subscribe to see more

$99M

Subscribe to see more

0

Date

9/23/2015

5/10/2011

2/19/2010

9/12/2008

7/16/2008

Round

Series C

Series D

Series B - II

Series C

Series A

Company

SevOne

BioSet

Tepha

Subscribe to see more

Subscribe to see more

Amount

$50M

$6.77M

$3M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

0

0

Westfield Capital Management Portfolio Exits

11 Portfolio Exits

Westfield Capital Management has 11 portfolio exits. Their latest portfolio exit was Tepha on July 27, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/27/2021

Acquired

$99M

3

11/4/2019

Acquired

$99M

3

7/1/2015

IPO

$99M

Public

1

5/7/2015

IPO

Subscribe to see more

$99M

Subscribe to see more

10

2/19/2015

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/27/2021

11/4/2019

7/1/2015

5/7/2015

2/19/2015

Exit

Acquired

Acquired

IPO

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

3

3

1

10

10

Westfield Capital Management Acquisitions

2 Acquisitions

Westfield Capital Management acquired 2 companies. Their latest acquisition was Radyne on February 16, 2004.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

2/16/2004

$99M

Acquired

10/7/1998

Debt

Subscribe to see more

$99M

$99M

Subscribe to see more

0

Date

2/16/2004

10/7/1998

Investment Stage

Debt

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$99M

Note

Acquired

Subscribe to see more

Sources

0

Westfield Capital Management Team

3 Team Members

Westfield Capital Management has 3 team members, including current Chief Executive Officer, Arthur J Bauernfeind.

Name

Work History

Title

Status

Arthur J Bauernfeind

Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Arthur J Bauernfeind

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.